Cardinal Health (NYSE: CAH) announced plans to acquire The Harvard Drug Group (THDG), a distributor of generic pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE